Clinical Trial Update: REVErsing Airway Remodelling With Tezepelumab [Phase 3]

View source ↗

Summary

Phase 3 trial update on tezepelumab targeting airway remodelling in asthma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Airway Remodeling in Asthma
• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Airway Remodelling, Asthmatic | Phase 3 | Status: COMPLETED